# Trial: DECLARE-TIMI58
## ID: DECLARE-TIMI58 (NCT ID not specified)

### Description
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events.

### Inclusion Criteria
- Provision of informed consent prior to any study specific procedures
- Female or male aged â‰¥40 years
- Diagnosed with Type 2 Diabetes
- High Risk for Cardiovascular events

### Exclusion Criteria
- Diagnosis of Type 1 diabetes mellitus
- History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
- Chronic cystitis and/or recurrent urinary tract infections
- Pregnant or breast-feeding patients
